Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 11-20 of 37 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2003Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, d-chiro-inositol) for polycystic ovary syndromeLord, J.; Flight, I.; Norman, R.; Tang, T.
1999No association between the -308 polymorphism in the tumour necrosis factor a (TNFa) promoter region and polycystic ovariesMilner, C.; Craig, J.; Hussey, N.; Norman, R.
1995Subjects with polycystic ovaries without hyperandrogenaemia exhibit similar disturbances in insulin and lipid profiles as those with Polycystic Ovary SyndromeNorman, R.; Hague, W.; Masters, S.; Wang, X.
1995Immunoactive interleukin-1b and tumour necrosis factor-a in thecal, stromal and granulosa cell cultures from normal and polycystic ovariesJasper, M.; Norman, R.
2012Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subferfilityTang, T.; Lord, J.; Norman, R.; Yasmin, E.; Balen, A.
2014Polycystic ovary syndrome: Perceptions and attitudes of women and primary health care physicians on features on PCOS and renaming the syndromeTeede, H.; Gibson-Helm, M.; Norman, R.; Boyle, J.
2010Serum antimullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS)Hart, R.; Doherty, D.; Norman, R.; Franks, S.; Dickinson, J.; Hickey, M.; Sloboda, D.
1997Circulating leptin concentrations in polycystic ovary syndrome: relation to anthropometric and metabolic parametersChapman, I.; Wittert, G.; Norman, R.
1999Thirty-seven candidate genes for polycystic ovary syndrome: Strongest evidence for linkage is with follistatinUrbanek, M.; Legro, R.; Driscoll, D.; Azziz, R.; Ehrmann, D.; Norman, R.; Strauss, J.; Spielman, R.; Dunaif, A.
2010Biomarkers: Polycystic ovary syndrome: steroid assessment for diagnosisHickey, T.; Norman, R.